620 related articles for article (PubMed ID: 35688210)
1. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
2. FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection.
Meng H; Liao Z; Ji Y; Wang D; Han Y; Huang C; Hu X; Chen J; Zhang H; Li Z; Wang C; Sun H; Sun J; Chen L; Yin J; Zhao J; Xu T; Liu H
Signal Transduct Target Ther; 2024 Apr; 9(1):104. PubMed ID: 38654010
[TBL] [Abstract][Full Text] [Related]
3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
4. ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.
Memon B; Abdelalim EM
Acta Physiol (Oxf); 2021 Dec; 233(4):e13733. PubMed ID: 34561952
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.
Wu CT; Lidsky PV; Xiao Y; Lee IT; Cheng R; Nakayama T; Jiang S; Demeter J; Bevacqua RJ; Chang CA; Whitener RL; Stalder AK; Zhu B; Chen H; Goltsev Y; Tzankov A; Nayak JV; Nolan GP; Matter MS; Andino R; Jackson PK
Cell Metab; 2021 Aug; 33(8):1565-1576.e5. PubMed ID: 34081912
[TBL] [Abstract][Full Text] [Related]
6. Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity.
Du K; Sun L; Luo Z; Cao Y; Sun Q; Zhang K; Faizy A; Piomelli D; Lu X; Shan J; Yang Q
Metabolism; 2022 Jun; 131():155181. PubMed ID: 35311662
[TBL] [Abstract][Full Text] [Related]
7. Do adipocytes serve as a reservoir for severe acute respiratory symptom coronavirus-2?
Steenblock C; Bechmann N; Beuschlein F; Wolfrum C; Bornstein SR
J Endocrinol; 2023 Aug; 258(2):. PubMed ID: 37227170
[TBL] [Abstract][Full Text] [Related]
8. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
Cao X; Song LN; Yang JK
Clin Sci (Lond); 2021 Feb; 135(3):535-554. PubMed ID: 33533405
[TBL] [Abstract][Full Text] [Related]
9. Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19.
Shin J; Toyoda S; Nishitani S; Fukuhara A; Kita S; Otsuki M; Shimomura I
Diabetes; 2021 Dec; 70(12):2745-2755. PubMed ID: 34615619
[TBL] [Abstract][Full Text] [Related]
10. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
11. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
Yang M; Li J; Deng S; Fan H; Peng Y; Ye G; Wang J; Wei J; Jiang X; Xu Z; Qing L; Wang F; Yang Y; Liu Y
Cells; 2022 Jan; 11(3):. PubMed ID: 35159296
[TBL] [Abstract][Full Text] [Related]
12. Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.
Roy D; Ramasamy R; Schmidt AM
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):614-627. PubMed ID: 33327744
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
Shao S; Yang Q; Pan R; Yu X; Chen Y
Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors.
Fignani D; Pedace E; Licata G; Grieco GE; Aiello E; de Luca C; Marselli L; Marchetti P; Sebastiani G; Dotta F
Diabetes Metab Res Rev; 2023 Nov; 39(8):e3696. PubMed ID: 37466955
[TBL] [Abstract][Full Text] [Related]
15. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
[TBL] [Abstract][Full Text] [Related]
16. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
Luo J; Lu S; Yu M; Zhu L; Zhu C; Li C; Fang J; Zhu X; Wang X
Gene; 2021 Feb; 768():145325. PubMed ID: 33253796
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
18. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
Li Z; Peng M; Chen P; Liu C; Hu A; Zhang Y; Peng J; Liu J; Li Y; Li W; Zhu W; Guan D; Zhang Y; Chen H; Li J; Fan D; Huang K; Lin F; Zhang Z; Guo Z; Luo H; He X; Zhu Y; Li L; Huang B; Cai W; Gu L; Lu Y; Deng K; Yan L; Chen S
Cell Metab; 2022 Mar; 34(3):424-440.e7. PubMed ID: 35150639
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
